About Technology Issues FAQ

Links

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.